Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure

The American Journal of Medicine
W S ColucciE Braunwald

Abstract

Vasodilators play an important role in the treatment of the patient with severe heart failure and increased systemic vascular resistance. However, there are both clinical data and theoretic reasons to anticipate that some degree of tolerance may develop during the long-term use of most agents. The cause of the increased vascular resistance of heart failure is not completely understood, but it appears to be related to a number of neuroendocrine, molecular and physical mechanisms including increased activity of the sympathetic nervous and renin-angiotensin systems, and increased vascular stiffness due to intra- and extracellular sodium and fluid accumulation. Not surprisingly, a lowering of systemic vascular resistance either by direct smooth muscle relaxers or by blockade of specific neuroendocrine systems may result in a number of compensatory responses at the neuroendocrine and/or molecular level. The over-all effectiveness of a particular vasodilator is the net sum of its direct pharmacologic action, and the neuroendocrine and molecular responses to the drug. The specific compensatory mechanisms activated depend on several factors including the type of vasodilator used, the dose employed, the baseline neuroendocrine status of...Continue Reading

References

May 1, 1976·Circulation Research·W A PettingerD C Harper
Sep 1, 1977·Life Sciences·S Berthelsen, W A Pettinger
Jun 1, 1976·The Journal of Clinical Investigation·L WatkinsA C Barger
Jul 28, 1977·The New England Journal of Medicine·G H Williams, N K Hollenberg
Feb 1, 1978·The American Journal of Cardiology·J A Thomas, B H Marks
May 7, 1979·Life Sciences·B B HoffmanR J Lefkowitz
Feb 1, 1975·The Journal of Clinical Investigation·W A Pettinger, K Keeton
Aug 4, 1977·The New England Journal of Medicine·J N Cohn, J A Franciosa
Oct 1, 1978·The American Journal of Cardiology·M Packer, J Meller
Jul 7, 1977·The New England Journal of Medicine·J N Cohn, J A Franciosa
Sep 1, 1979·The American Journal of Cardiology·U ElkayamE H Sonnenblick
Sep 1, 1979·Annals of Internal Medicine·S B ArnoldK Chatterjee
Jan 1, 1977·Physiology & Behavior·J H StrubbeL De Ruiter
Feb 1, 1976·Circulation·R B KovickK I Shine
Dec 1, 1976·Circulation·K ChatterjeeA Norman
Aug 11, 1977·The New England Journal of Medicine·E Braunwald
Apr 1, 1972·The Journal of Clinical Investigation·C B HigginsE Braunwald
Aug 1, 1970·The Journal of Pharmacy and Pharmacology·B AbladB Waldeck
Jul 1, 1974·Biochemical Pharmacology·S Z Langer
Jul 26, 1973·The New England Journal of Medicine·J Koch-Weser

❮ Previous
Next ❯

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·D N Sharpe, R Coxon
Feb 1, 1990·Cardiovascular Drugs and Therapy·R J Katz
Feb 16, 1984·The New England Journal of Medicine·E Braunwald, W S Colucci
Apr 1, 1989·British Heart Journal·J S ElbornD P Nicholls
Nov 1, 1992·The Journal of Clinical Investigation·J VincentB B Hoffman
Jul 9, 1988·BMJ : British Medical Journal·A D Timmis
Jun 1, 1990·Clinical Cardiology·G J HaasC V Leier
Apr 12, 2011·The Canadian Journal of Cardiology·Paula A RozenfeldGustavo J Rinaldi
May 1, 1992·The American Journal of Medicine·E J Eichhorn
Sep 24, 1992·The American Journal of Cardiology·U ElkayamE Ostrzega
Sep 1, 1993·American Heart Journal·C RichardJ F Giudicelli
Oct 1, 1986·The American Journal of Cardiology·R S KohliE B Raftery
Feb 1, 1989·Journal of Clinical Pharmacy and Therapeutics·M K Davies
Jan 1, 1982·British Journal of Clinical Pharmacology·G LiebauS Oehrlein
Feb 1, 1983·American Heart Journal·L T Iseri, D J Benvenuti
Jun 1, 1984·Journal of the American College of Cardiology·E Braunwald, W S Colucci
Aug 1, 1983·Journal of the American College of Cardiology·B M MassieD T Combs
Mar 1, 1985·Journal of the American College of Cardiology·M A FiferW H Barry
Dec 1, 1985·Research in Nursing & Health·K L McCanceR R Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.